EUCTR2006-006088-22-DE进行中(未招募)1 期
Prospective multicenter phase III clinical trial using cytoreductive surgery with hyperthermic intraoperative chemotherapy (HIPEC) after preoperative chemotherapy in patients with peritoneal carcinomatosis of gastric cancer incl. adenocarcinoma of the esophagogastreal junction - Gastripec I
Klinik für Chirurgie, Charité Campus Virchow-Klinikum0 个研究点目标入组 180 人开始时间: 2011年2月14日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 180
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1) patients with gastric cancer incl. adenocarcinoma of the esophagogastreal junction and peritoneal carcinomatosis without any distant metastases with exception of Krukenberger tumosr
- •2) peritoneal staging via laparoscopy and assessment of peritoneal carcinomatosis index (PCI) with the possibility of reduction (80% of the tumour) in line with zytoreductive surgery
- •3) age = 18 and = 75 years
- •4) Karnofsky Index = 70%
- •5) written informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 180
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 180
排除标准
- •1.) distant metastases except peritoneal carcinomatosis and Krukenberg tumors
- •2.) other malignoma except curatively treated cervix carcinoma and basal cell carcinoma of the skin
- •3.) previous chemotherapy or radiotherapx for peritoneal carcinomatosis
- •4.) Inflammation in need of treatment
- •5.) NYHA > 2
- •6.) Myocardial infarction
- •7.) cardiac arrhythmia
- •8.) high blood pressure, constant > 180/100
- •9.) cardiac function EF < 55%
- •10.) Limited heart function
- •11.) Insufficient renal function
- •12.) Insufficient liver function
- •13.) vaccinations during the last 6 weeks
- •14.) Active hepatitis B/C
- •15.) Pregnancy / lactation
- •16.) No effective contraception
- •17.) Missing of capacity to contract
- •18.) contraindication to the drugs which are used in the trial
- •19.) Participation in another investigational drug trial
- •20.) Persons institutionalised due to regulatory actions ore by court order.
研究者
相似试验
已完成
3 期
Prospective multicenter phase III clinical trial using cytoreductive surgery with hyperthermic intraoperative chemotherapy (HIPEC)after preoperative chemotherapy in patients with peritoneal carcinomatosis of gastric cancer incl. adenocarcinoma of the esophagogastreal junctioMedDRA - 10042080 (stomach cancer)C16D00.2C78.6C79Malignant neoplasm of stomachStomachSecondary malignant neoplasm of retroperitoneum and peritoneumSecondary malignant neoplasm of other and unspecified sitesDRKS00003078Charité Campus Charité Mitte105
招募中
3 期
Prospective randomized multicenter phase III trial of decitabine and venetoclax administered in combination with all-trans retinoic acid or placebo in patients with acute myeloid leukemia who are ineligible for induction chemotherapyC92Myeloid leukaemiaDRKS00023646niversitätsklinikum Freiburg256
已完成
2 期
A clinical trial with Sodium Thiosulfate for the treatment of CalciphylaxisCalciphylaxisCirculatory SystemISRCTN73380053Dr. F. Köhler Chemie GmbH (Germany)5
进行中(未招募)
1 期
Phase 2/3 Clinical Trial with Sodium Thiosulfate for the Treatment of CalciphylaxisCalciphylaxisMedDRA version: 20.0Level: PTClassification code 10051714Term: CalciphylaxisSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2014-002128-28-ATDr. F. Köhler Chemie GmbH40
进行中(未招募)
1 期
Phase 2/3 Clinical Trial with Sodium Thiosulfate for the Treatment of CalciphylaxisCalciphylaxisMedDRA version: 20.0Level: PTClassification code 10051714Term: CalciphylaxisSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2014-002128-28-DEDr. F. Köhler Chemie GmbH40
